Novel CB1 receptor antagonists: phase II
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN271200577424C
- Awardee
-
Makscientific LLC UEI J2NHTDAJGK24
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $750,000
Award facts
- Contract value 100% obligated
- $750,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Not Available for Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- West Mystic, CT 06388, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $17,501 | |
| Original award | $732,499 |
Quick answers
Who was awarded contract HHSN271200577424C?
HHSN271200577424C was awarded to Makscientific LLC by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2005.
How much is contract HHSN271200577424C worth?
The government has obligated $750,000 on HHSN271200577424C.
Was contract HHSN271200577424C competed?
The extent of competition for HHSN271200577424C was not available for competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award